Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Stepan Co
SCL
$1.47B
| $2.48M | ﹤0.01% |
25,517
-335
| -1% | -$31.5K |
|
1902
PUT
Harley-Davidson
HOG
$2.72B
| $2.47M | ﹤0.01% |
103,900
+11,700
| +13% | +$254K |
|
|
KYNB
1903
Kyntra Bio
KYNB
$28.2M
| $2.47M | ﹤0.01% |
2,435
-3,187
| -57% | -$2.96M |
|
1904
Essential Properties Realty Trust
EPRT
$6.53B
| $2.47M | ﹤0.01% |
166,209
-25,590
| -13% | -$352K |
|
|
GWPH
1905
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.46M | ﹤0.01% |
20,082
-10,870
| -35% | -$1.23M |
|
|
CIM
1906
Chimera Investment
CIM
$980M
| $2.46M | ﹤0.01% |
85,379
-247,127
| -74% | -$6.35M |
|
1907
Sturm, Ruger & Co
RGR
$594M
| $2.46M | ﹤0.01% |
32,392
-4,871
| -13% | -$296K |
|
1908
PUT
MasTec
MTZ
$21.5B
| $2.46M | ﹤0.01% |
54,800
-232,300
| -81% | -$8.8M |
|
|
AXON
1909
CALL
Axon Enterprise
AXON
$48.4B
| $2.45M | ﹤0.01% |
25,000
-2,700
| -10% | -$218K |
|
|
AXON
1910
PUT
Axon Enterprise
AXON
$48.4B
| $2.45M | ﹤0.01% |
25,000
+13,100
| +110% | +$1.06M |
|
1911
PUT
Valero Energy
VLO
$90.7B
| $2.45M | ﹤0.01% |
41,700
-118,600
| -74% | -$7.08M |
|
1912
CALL
MetLife
MET
$61.7B
| $2.45M | ﹤0.01% |
67,100
-107,300
| -62% | -$3.74M |
|
|
ISBC
1913
DELISTED
Investors Bancorp, Inc.
ISBC
| $2.45M | ﹤0.01% |
288,314
+212,077
| +278% | +$1.78M |
|
|
ELME
1914
Elme Communities
ELME
$144M
| $2.45M | ﹤0.01% |
110,299
-6,217
| -5% | -$138K |
|
1915
Selective Insurance
SIGI
$5.66B
| $2.45M | ﹤0.01% |
46,450
+26,999
| +139% | +$1.37M |
|
|
CXP
1916
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $2.45M | ﹤0.01% |
186,365
+121,670
| +188% | +$1.6M |
|
1917
Erie Indemnity
ERIE
$13.2B
| $2.45M | ﹤0.01% |
12,747
+4,477
| +54% | +$788K |
|
1918
AeroVironment
AVAV
$9.57B
| $2.44M | ﹤0.01% |
30,660
-733
| -2% | -$47.2K |
|
1919
Lattice Semiconductor
LSCC
$18.2B
| $2.43M | ﹤0.01% |
85,563
+30,731
| +56% | +$718K |
|
1920
Northern Oil and Gas
NOG
$2.56B
| $2.43M | ﹤0.01% |
289,465
+255,181
| +744% | +$2.18M |
|
1921
NETSCOUT
NTCT
$2.81B
| $2.42M | ﹤0.01% |
94,780
-50,971
| -35% | -$1.32M |
|
|
PXD
1922
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $2.42M | ﹤0.01% |
24,800
-30,300
| -55% | -$2.67M |
|
|
AMRN
1923
CALL
Amarin Corp
AMRN
$298M
| $2.42M | ﹤0.01% |
17,475
-35,540
| -67% | -$4.89M |
|
1924
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
| $2.42M | ﹤0.01% |
22,823
-1,304
| -5% | -$136K |
|
|
SRNE
1925
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.41M | ﹤0.01% |
384,276
+172,071
| +81% | +$659K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.